1. A 3x2 factorial experiment was conducted with three diets and two lines of broiler breeder females to evaluate the contribution of low-energy rations for improving the welfare of feed-restricted birds during rearing. Experimental diets were fed from 6 to 16 weeks of age and were created by diluting a conventional grower (Control) ration containing 11.0 MJ ME/kg with 200 (8.8 MJ ME/kg) or 400 (6.6 MJ ME/kg) g oat hulls/kg using Optimoist to facilitate the pelleting process. Welfare was assessed by changes in behaviour and physiological variables at 8, 12 and 16 weeks of age. Birds were fed restricted quantities of feed to meet recommended body weight targets. 2. There was a decrease in the proportion of observations of drinking and an increase of preening in birds fed on the two experimental diets compared with the control. There was a linear decrease in litter moisture and the number of litter changes with increasing diet dilution, and water intake at 12 weeks was higher in the control than in the two experimental diets. There were no changes in physiological indexes of welfare (heterophil-lymphocyte ratio, plasma corticosterone and antibody responses) associated with the dietary treatments. 3. There were no important differences in the growth, behaviour or physiological responses to dietary treatment between the two lines of broiler breeders. Changes with age were similar to those reported in other experiments. 4. It was concluded that low-energy pelleted diets would improve litter conditions but not improve indexes of welfare in feed-restricted broiler breeders.

A major complication of irradiation therapy for head and neck cancer is salivary gland dysfunction and xerostomia. The purpose of this clinical investigation was to evaluate the effects of a commercially available oral moisturizer (Optimoist) on salivary flow rate, symptoms of xerostomia, oral pH, oral microflora, and swallowing in postirradiation head and neck cancer patients (XRT) and patients with Sjögren's syndrome (SS). Subjects who were post-XRT and subjects with SS (n = 24; mean age = 54.1) discontinued their use of any salivary substitute or moisturizer for 2 weeks prior to entering the study. Baseline whole unstimulated saliva was collected for 5 minutes using a standard sialometric technique. Candida albicans and Lactobacillus cultures were performed using kits from Orion Diagnostica, Inc., and a pH analysis was performed on the salivary sample using a Markson (model 00663) pH meter. Swallowing was assessed by clinical measures by videofluoroscopic techniques. Several subjective assessments were performed to evaluate symptoms of xerostomia. Subjects were instructed in the use of a daily diary and to use only the provided article ad libitum for a period of 2 weeks. After the 2-week period, the results indicated significant subjective and objective improvements in signs and symptoms of xerostomia. Whole unstimulated salivary flow rate improved from (mean +/- SEM) 0.1150 +/- 0.02 to 0.2373 +/- 0.09 mL/min. Salivary pH did not change. Global subjective improvement in xerostomia improved in 58% of the subjects. Candida colonization decreased in 43% of the subjects. There was no change in Lactobacilli colonization. Swallowing objectively improved in 75% of subjects. These results indicate significant improvement in both signs of hyposalivation and symptoms of xerostomia with the use of Optimoist in postirradiation head and neck cancer patients and patients with SS.

The physical and chemical stability of amphotericin B in a mixture of Fungizone and Optimoist was studied. The mixture was prepared by mixing equal volumes of Fungizone and Optimoist. The rate of sedimentation of amphotericin B was evaluated in Fungizone, Fungizone:Optimoist (1:1) and Fungizone:distilled water (1:1) mixture. The chemical stability of amphotericin B in a mixture of Fungizone:Optimoist (1:1) was determined by high-performance liquid chromatography from samples stored at different temperatures. The rate of sedimentation was faster when Fungizone was mixed with distilled water as compared to Optimoist. Amphotericin B was stable for three weeks stored in the refrigerator (4 deg C) and for three weeks at room temperature (25 deg C). Fungizone can be diluted with Optimoist for topical application. The mixture should be shaken well before administration in order to disperse any sediment.